Clinician-led Weight Loss

Medical weight loss.
Not willpower.

Obesity is a complex metabolic condition, not a character flaw. Our clinician-led GLP-1 programmes address the underlying biology of weight gain with clinically proven medications, clinical monitoring, and genuine support.

Woman laughing during a phone call at home

Eligibility criteria.

BMI ≥ 30 BMI ≥ 27 with comorbidities Both genders Ages 18-75

Want to know where you stand before booking a consultation?

Check your eligibility
GPhC-registered prescriber
Every case personally reviewed
Safety-first ongoing monitoring
Discreet UK delivery

The most effective obesity medicines available

GLP-1 receptor agonists are the most significant advance in obesity medicine in decades. Each is prescribed following a full clinical assessment.

Semaglutide (Wegovy)
Weekly subcutaneous injection

The landmark STEP trials showed an average 15% body weight loss over 68 weeks, more than double any previous medication. A once-weekly pen injection that fits easily into your routine.

Average 15% body weight loss
Once-weekly dosing
Cardiovascular benefit demonstrated
Tirzepatide (Mounjaro)
Weekly subcutaneous injection

A dual GIP/GLP-1 agonist with SURMOUNT trial data showing up to 22.5% average body weight loss, the most effective obesity medication to date. Now available in the UK.

Up to 22.5% weight loss
Dual-mechanism action
Superior to semaglutide in head-to-head data
Coming soon
Semaglutide (Wegovy pill)
Once-daily tablet

The oral form of Wegovy, for patients who'd rather avoid injections. Same active ingredient, same weight-loss licence, in tablet form.

Simple, transparent pricing

Priced by dose, so you only ever pay for what you're actually on. Your clinician sets your starting dose and adjusts it based on how you respond, and your price moves with it.

Tirzepatide (Mounjaro)

Weekly injection, priced by dose

2.5mg£175 / mo
5mg£190 / mo
7.5mg£245 / mo
10mg£275 / mo
12.5mg£295 / mo
15mg£310 / mo
Semaglutide (Wegovy)

Weekly injection, priced by dose

0.25mg£120 / mo
0.5mg£120 / mo
1mg£150 / mo
1.7mg£190 / mo
2.4mg£255 / mo

Prices include your medication and delivery. Your consultation and ongoing clinician reviews are included in your programme. Prices are indicative and confirmed after your clinical assessment.

How GLP-1 medications work.

These are not stimulants or appetite suppressants. They work with your body's own metabolic signalling systems.

Appetite regulation

GLP-1 agonists act on hypothalamic receptors to reduce appetite and increase satiety signals, meaning you feel full on less food, without willpower or restriction.

Gastric emptying

These medications slow the rate at which food leaves the stomach, prolonging fullness and reducing post-meal blood glucose spikes, a key driver of hunger and cravings.

Metabolic benefit

Beyond weight loss, GLP-1 agonists reduce cardiovascular risk, improve glycaemic control, and have shown benefits in fatty liver disease and metabolic syndrome.

What's included in your programme.

Everything you need, nothing you don't. A complete clinical programme from assessment to ongoing monitoring.

Video consultation

Initial consultation with your clinician to assess medical history, BMI, and suitability for GLP-1 therapy.

Medication

Monthly supply of your prescribed GLP-1 medication dispatched from a GPhC-registered pharmacy partner. Discreet, temperature-controlled delivery.

Dose titration

Gradual dose increases as per clinical protocol to minimise side effects and maximise efficacy throughout your programme.

Ongoing support & reviews

Regular clinician check-ins to assess progress and adjust your protocol, with unlimited messaging between reviews and bloodwork where clinically appropriate.

How your programme works

01

Tell us about your medical history, current medications, and weight loss goals. Takes 5 minutes.

02
Video consultation with GPhC-registered pharmacist prescriber

A private 30-minute consultation, including whether bloodwork is needed. Your clinician selects the right medication and starting dose for you.

03
Medication dispatched monthly, ongoing reviews included

Your medication arrives monthly, with clinician check-ins to keep your programme on track.

FAQ

Common questions

The GLP-1 medications we prescribe are the gold-standard treatments for weight loss. Common side effects include nausea and GI discomfort, particularly during dose escalation. These typically improve after the first few weeks. Your clinician reviews your medical history for contraindications before prescribing.

Results vary, but clinical trial averages are: Semaglutide (Wegovy) ~15%, Tirzepatide (Mounjaro) ~22.5%. Individual results depend on adherence, lifestyle, and metabolic factors.

The medications work on their own, but pairing them with better diet and activity gets you further, and it's what makes the results stick once you come off treatment.

Weight regain is common after stopping GLP-1 therapy. This reflects the chronic nature of obesity as a condition. We work with patients on long-term maintenance strategies.

Yes. Our weight loss programme is open to both men and women. Eligibility criteria apply regardless of gender. Women who are pregnant or breastfeeding are not eligible.

Start your medical weight loss programme.

No fad diets. No willpower lectures. Just evidence-based medicine, delivered privately.